about
A novel allosteric pathway of thrombin inhibition: Exosite II mediated potent inhibition of thrombin by chemo-enzymatic, sulfated dehydropolymers of 4-hydroxycinnamic acidsAn anticoagulant RNA aptamer that inhibits proteinase-cofactor interactions within prothrombinaseSerpinC1/Antithrombin III in kidney-related diseasesDesigning nonsaccharide, allosteric activators of antithrombin for accelerated inhibition of factor Xa.Genome-wide identification and immune response analysis of serine protease inhibitor genes in the silkworm, Bombyx moriZymogen-like factor Xa variants restore thrombin generation and effectively bypass the intrinsic pathway in vitroIdentification of antithrombin-modulating genes. Role of LARGE, a gene encoding a bifunctional glycosyltransferase, in the secretion of proteins?Matriptase is inhibited by extravascular antithrombin in epithelial cells but not in most carcinoma cellsIntracellular proteoglycans.Anti-thrombin is expressed in the benign prostatic epithelium and in prostate cancer and is capable of forming complexes with prostate-specific antigen and human glandular kallikrein 2.Hemostatic agents of broad applicability produced by selective tuning of factor Xa zymogenicity.Identification of Regulatory Mutations in SERPINC1 Affecting Vitamin D Response Elements Associated with Antithrombin Deficiency.Mutation of the H-helix in antithrombin decreases heparin stimulation of protease inhibition.Serpins in thrombosis, hemostasis and fibrinolysisFunctional consequences of the prothrombotic SERPINC1 rs2227589 polymorphism on antithrombin levelsOn designing non-saccharide, allosteric activators of antithrombin.Capillary electrophoretic study of small, highly sulfated, non-sugar molecules interacting with antithrombin.Elucidating the specificity of non-heparin-based conformational activators of antithrombin for factor Xa inhibition.Recurrent mutations in a SERPINC1 hotspot associate with venous thrombosis without apparent antithrombin deficiency.Biochemical and cellular consequences of the antithrombin p.Met1? mutation identified in a severe thrombophilic family
P2860
Q24652951-16C9F7C6-C1CF-435F-8179-F06D8B7984BAQ33519836-58CBC0D1-49E7-4D4E-A671-0E41FD98E080Q33578786-6F9236AD-E375-4161-9125-B5668A3EB73CQ33975255-AE134735-66A4-4F8B-A73B-F4DE1CBDAD81Q34163396-A2F69C22-68E5-47A5-AF57-EEBF2B15FDACQ34568888-69F47103-0374-417A-95E0-6961C1BEA7BCQ34738273-5D709912-002A-4286-AEA6-895942F6A812Q35543249-1B13068E-CF04-4603-B030-0065C97F6DDAQ35647324-58D3B3B0-B9D9-415C-9F98-68564881B41DQ35748176-F0B6EF56-69FC-47D0-98C2-1A97CE80F496Q35820397-3FF11A49-92A9-4490-926E-0902728F2D1CQ35966475-60F2F1BA-8757-44F1-8C32-4D2BF562C115Q36408211-78E2508A-B978-4E3E-B5CD-E955406BC941Q36884340-BA683847-FB79-43E0-A02B-BED27CB54E59Q37146081-89FCE1AD-420A-484A-AD98-ED4442BE529EQ37345593-837C6305-7DD6-4866-B3F0-E43926EB525DQ37371255-9D2313A4-5993-411F-9E49-2C0ABE357398Q37654381-1CD7FE04-4E0B-4204-A6FE-7CA1B9EA2B6DQ49252439-8A15856A-D38C-4F4B-A99A-286CFD1145C8Q58764405-886FA302-2642-4AE0-816D-51CB6B59F0B4
P2860
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Antithrombin. A bloody important serpin.
@en
type
label
Antithrombin. A bloody important serpin.
@en
prefLabel
Antithrombin. A bloody important serpin.
@en
P1476
Antithrombin. A bloody important serpin
@en
P2093
P407
P577
1997-01-01T00:00:00Z